Additional Information About Source of Study Drug and Typographical Error in Supplement

No authors listed

Published Erratum

No authors listed. JAMA Intern Med. 2022.

. 2022 Jun 1;182(6):690.

doi: 10.1001/jamainternmed.2022.1523.

No abstract available

Erratum for

Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities: The I-TECH Randomized Clinical Trial.
Lim SCL, Hor CP, Tay KH, Mat Jelani A, Tan WH, Ker HB, Chow TS, Zaid M, Cheah WK, Lim HH, Khalid KE, Cheng JT, Mohd Unit H, An N, Nasruddin AB, Low LL, Khoo SWR, Loh JH, Zaidan NZ, Ab Wahab S, Song LH, Koh HM, King TL, Lai NM, Chidambaram SK, Peariasamy KM; I-TECH Study Group. Lim SCL, et al. JAMA Intern Med. 2022 Apr 1;182(4):426-435. doi: 10.1001/jamainternmed.2022.0189. JAMA Intern Med. 2022. PMID: 35179551 Free PMC article. Clinical Trial.

1. Lim SCL, Hor CP, Tay KH, et al. ; I-TECH Study Group . Efficacy of ivermectin treatment on disease progression among adults with mild to moderate COVID-19 and comorbidities: the I-TECH randomized clinical trial. JAMA Intern Med. Published online February 18, 2022. doi:10.1001/jamainternmed.2022.0189 - DOI - PMC - PubMed